ApconiX Welcomes Dr Karin Burnett to The Team

ApconiX Welcomes Dr Karin Burnett to The Team ApconiX is delighted to welcome Dr Karin Burnett, an experienced project toxicologist with a broad knowledge of toxicology and chemical risk assessment in the pharmaceutical industry.  Karin will join the team of experts in nonclinical safety toxicology at ApconiX, who cover all [...]

By |2022-12-13T18:15:17+00:00December 12th, 2018|Careers, Target Safety Assessments|Comments Off on ApconiX Welcomes Dr Karin Burnett to The Team

Highlight Article for Experimental Biology and Medicine

Highlight Article for Experimental Biology and Medicine “Drug discovery and development: Biomarkers of neurotoxicity and neurodegeneration”, co-authored by Abigail L Walker, Syed Z Imam and  Ruth A Roberts, has been selected as a highlight article for Experimental Biology and Medicine’s 243:13 issue. As a result of this designation it [...]

By |2022-12-13T18:16:22+00:00December 7th, 2018|Publications|Comments Off on Highlight Article for Experimental Biology and Medicine

ApconiX Welcomes Phumzile Sikakana to The Team

ApconiX Welcomes Phumzile Sikakana to The Team ApconiX is delighted to welcome Phumzile Sikakana who joins us straight from University.  Phum, an enthusiastic new master's graduate will work with our team of experienced scientists on a variety of projects, including target safety reviews and in the ion channel screening [...]

By |2023-02-08T16:33:35+00:00December 5th, 2018|Target Safety Assessments, Careers|Comments Off on ApconiX Welcomes Phumzile Sikakana to The Team

Insider Breakfast Golden Triangle Breakfast Event

Insider Breakfast Golden Triangle Breakfast Event Professor Ruth Roberts was thrilled to be invited to speak at Business Insider’s recent Golden Triangle Breakfast Event at Alderley Park in the Northwest.  The new golden triangle is part of a vision to take the Cheshire Science Corridor and create a golden [...]

By |2022-12-13T18:18:45+00:00November 29th, 2018|Events|Comments Off on Insider Breakfast Golden Triangle Breakfast Event

Making Safety a Part of Drug Design

Making Safety a Part of Drug Design The Global Antibiotic R&D Partnership (GARDP) will host a live webinar with ApconiX's Dr Claire Sadler on ''Making safety a part of drug design" on 13th November 16.00-17.30 GMT.  Claire is an expert discovery project toxicologist specialising in early project safety assessment [...]

By |2023-09-28T12:32:32+01:00November 2nd, 2018|Events|Comments Off on Making Safety a Part of Drug Design

Target Safety Reports: What’s in a Name?

Target Safety Reports: What's in a Name? Irrespective of what we call them, target safety reports form a key part of risk assessment and risk mitigation plans in drug discovery and development. Why is that?  Well, target-related toxicity accounts for >50% of all drug project failures (Cook et al., [...]

By |2022-12-13T18:25:53+00:00October 12th, 2018|Target Safety Assessments|Comments Off on Target Safety Reports: What’s in a Name?

ApconiX Welcomes Bethany Russell

ApconiX Welcomes Bethany Russell Bethany joins ApconiX as a placement student for part of September.  A second-year student, Bethany is studying Biomedical Sciences at Sheffield University.  Her degree is a four-year sandwich course, with a third-year placement in industry. Bethany was unsure if a career in a laboratory was [...]

By |2022-12-13T18:27:00+00:00October 4th, 2018|Ion Channels, Careers|Comments Off on ApconiX Welcomes Bethany Russell

Collaboration and competition: ethics in toxicology

Collaboration and competition: ethics in toxicology What are our attitudes to research resourcing, publication and the peer review system?  The British Toxicology Society (BTS) is conducting a survey to establish attitudes of toxicologists to key questions such as ‘I believe collaboration to be important in driving toxicology research in [...]

By |2022-12-13T18:27:59+00:00September 27th, 2018|Toxicology|Comments Off on Collaboration and competition: ethics in toxicology

ApconiX is supporting PhysioStim at SPS

ApconiX is supporting PhysioStim at SPS ApconiX and PhysioStim will be celebrating their first year of The European Centre of Excellence for preclinical cardiovascular electrophysiology at the Safety Pharmacology Society Annual Meeting in Washington this September.  ApconiX will be supporting PhysioStim as they exhibit at the Marriott Wardman Park [...]

By |2022-12-13T18:29:03+00:00September 26th, 2018|Ion Channels, Events|Comments Off on ApconiX is supporting PhysioStim at SPS

Choosing the right non-clinical CRO

Choosing the right non-clinical CRO Non-clinical contract research organisations (CROs) are an integral part of modern drug development. For any novel agent, delivery of GLP toxicity data to support clinical trials is a crucial step that requires a professional organisation with dedicated management, infrastructure and a broad array of technical [...]

By |2024-01-23T10:53:49+00:00September 19th, 2018|Press, Toxicology|Comments Off on Choosing the right non-clinical CRO
Go to Top